Sort
82,697 grants matching “vaccine development”
Analysis of Host-Pathogen Interactions
$849,013Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Biomedical Studies and Atomic Force Microscopy
$848,997Albert J Jin · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
$848,928Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2024 · AI
Hepatitis C: Studies of Immunity and Pathogenesis
$848,905Rockefeller University · U19 · FY2005 · AI
Novel Targets for Vaccine Therapy
$848,816Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Broad spectrum inhibitors of paramyxovirus envelope proteins
$848,745Anne Moscona · Columbia University Health Sciences · R01 · FY2023 · AI
Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine
$848,727Joana Carneiro Da Silva · University Of Maryland Baltimore · R01 · FY2019 · AI
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
$848,656Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI
Malaria Vaccine: Pfs230
$848,566Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors
$848,532Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2019 · AI
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$848,466Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2017 · AI
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
$848,444Edward Hook · University Of Alabama At Birmingham · N01 · FY2024 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$848,411Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Signal Transduction Events and the Regulation of Cell Growth
$848,376Jane Neckers · Division Of Clinical Sciences - Nci · ZIC · FY2017 · CA
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
$848,374Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
$848,314Gwendolyn B. Scott · University Of Miami School Of Medicine · U01 · FY2009 · AI
Preclinical development of an immunomodulatory agent capable of mitigating influenza related hypercytokinemia
$848,308Jodi K Craigo · Cytoagents, Inc. · R44 · FY2020 · AI
Mapping spatiotemporal dynamics during enterovirus infection across cells and tissues
$848,303Raul Andino · University Of California, San Francisco · R01 · FY2024 · AI
Mapping spatiotemporal dynamics during enterovirus infection across cells and tissues
$848,303Raul Andino · University Of California, San Francisco · R01 · FY2023 · AI
Natural History of HPV Infection to Neoplasia
$848,301Anna-Barbara None Moscicki · University Of California Los Angeles · R37 · FY2014 · CA
Production of Non-Egg grown Influenza Vaccines
$848,254Novavax, Inc. · UC1 · FY2000 · AI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$848,166Christopher B Fox · Access To Advanced Health Institute · R01 · FY2020 · AI
Role of the microbiome in HIV vaccine induced heterogeneity
$848,148James G. Kublin · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI
Antibody Based Therapeuticcs for Chikungunya Virus
$848,100Michael S. Diamond · Washington University · R01 · FY2010 · AI
Task C12: Infectivity and Lethality of Filovirus strain(s) in NHP
$848,083Alan D.t. Barrett · University Of Texas Med Br Galveston · N02 · FY2014 · AI